The largest database of trusted experimental protocols

Irf4 antibody

Manufactured by Cell Signaling Technology
Sourced in China, United States

The IRF4 antibody is a laboratory reagent used to detect the presence and expression levels of the Interferon Regulatory Factor 4 (IRF4) protein in biological samples. IRF4 is a transcription factor that plays a role in the regulation of immune system and cell differentiation processes. This antibody can be used in various laboratory techniques, such as Western blotting, immunohistochemistry, and flow cytometry, to analyze IRF4 expression and distribution in cells and tissues.

Automatically generated - may contain errors

2 protocols using irf4 antibody

1

Comprehensive IgE Antibody Detection Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
A peroxidase-labeled mouse anti-human IgE Fc antibody and peroxidase-labeled goat anti-mouse IgE, IgG1 and IgG2a Fc antibodies were obtained from SouthernBiotech, USA (9160-05, 1110-05, 1070-05 and 1155-05); tetramethylbenzidine (TMB) was purchased from Solarbio, China (R1200); aluminum hydroxide was obtained from Thermo Fisher, USA (77161); and LPS was purchased from Sigma, USA (L3012). ELISA kits for IL-4, IFN-γ and TNF-α were obtained from Ebioscience, USA (88-7044, 88–7314 and 88–7324); ELISA kits for IL-5 and IL-13 were purchased from 4 A Biotech, China (CME0003, CME0009); an IRF4 antibody was obtained from Cell Signaling, USA (4964); an antibody against GAPDH was procured from Proteintech, China (10494-1-AP); a TLR4 signaling inhibitor was purchased from Invivogen, USA (CLI-095); an anti-mouse TLR2 Ab was obtained from Biolegend, USA (121802); the PE-CD80, PE-CD83, FITC-MHCII and FITC-CD40 antibodies were obtained from Ebioscience, USA (12–0801, 12–0831, 11–5321 and 11–0402); and mouse GM-CSF and IL-4 were purchased from Sino Biological, China (51048-M07H, 51084-M08B). Anti-CD3 and anti-CD28 antibodies were obtained from Ebioscience, USA (16-0031-82, 16-0281-82).
+ Open protocol
+ Expand
2

Melanoma Cell Line Apoptosis Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Two cell lines defined as lethal by CRISPR screening (RVH421 and WM1799) and two non‐lethal (WM983B and HT144) melanoma cell lines were transfected with siRNAs. These siRNAs were ON‐TARGETplus SMARTpools (Dharmacon, Lafayette, CO, USA) designed against interferon regulatory factor 4 (IRF4), ERH (positive control/essential gene) or with a non‐targeting pool (negative control) according to the manufacturer's instructions. Cells were retransfected after 3 or 6 days and harvested for analysis after 10 days. Cells were stained with Annexin V‐PE (Biolegend, San Diego, CA, USA) and DAPI (Sigma‐Aldrich, St. Louis, MO, USA) and analysed by flow cytometry using a BD Fortessa II and FlowJo version 10 (Becton Dickinson, Franklin Lakes, NJ, USA). Successful gene knock‐down was confirmed by western blot analysis using an IRF4 antibody (Cell Signaling Technology, Danvers, MA, USA). GAPDH (Cell Signaling Technology, clone 14C10) or vinculin (Sigma‐Aldrich, clone V284) were used as loading controls. Cells were also analysed for c‐MYC protein expression using antibody clone Y69 (Abcam, Cambridge, UK).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!